Searched for
MOHALI PLANT
India emerges as global tech partner under PM Modi's 12-yr tenure, exporting to US, China: VaishnawIndia is now a trusted partner in technology value chains. Under Prime Minister Narendra Modi, the country exports electronics, including c...- India’s lost chip dream: The mysterious 1989 fire that may have cost the nation the AI raceIndia began semiconductor manufacturing before Taiwan Semiconductor Manufacturing Company. A fire in 1989 and policy neglect stalled progre...
- Rs 1,000 fine for wasting water in Mohali to start from this date: Check graded penalty amounts and areas under new rulesMohali residents face a ₹1,000 fine from April 15 for water wastage during morning hours, including hose pipe use for lawns, vehicles, or c...
- USFDA conducting inspection of Mohali plant: Sun PharmaThe inspection by the United States Food and Drug Administration (USFDA) started on September 10, 2018 and is ongoing, Sun Pharma said in a...
- Godrej Appliances to invest Rs 200 crore in Shirwal plant"The proposed expansion, once complete, will allow us to meet the increasing demand of premium products from Indian customers and expand ou...
- Sun Pharma rallies 7% as USFDA lifts import alert on Mohali unitThe Mohali facility was inherited by Sun Pharma as part of its acquisition of Ranbaxy Laboratories in 2015.
- Ranbaxy's hunt for FDA-okayed plants in India pushes stock higherRanbaxy is looking at FDI-okayed plants in an attempt to reduce risks arising out of issues with its Mohali plant, said two persons familia...
- Ranbaxy hunts for FDA-okayed plants in IndiaThis move will ensure launch plans are not jeopardised following Mohali setback.
- Daiichi to cooperate with USFDA to resolve Ranbaxy concernsDaiichi Sankyo will work with US authorities to resolve issue of a ban imposed by USFDA on import of drugs from Mohali plant of Ranbaxy.
- UK, Australia regulators seek details of US findings on Ranbaxy’s Mohali plantA spokesperson from UK drug regulator told ET that the agency is in touch with the US FDA to assess how this ban would affect Ranbaxy drugs...
- Ranbaxy seeks to assuage shareholders' worries after USFDA banRanbaxy Laboratories today sought to assuage concerns of shareholders in the wake of company's stock price taking a hard knock.
- Certain consent decree terms to apply to Mohali unit: RanbaxyThe decree contains provisions to ensure CGMP (Current Good Manufacturing Practices) compliance at certain Ranbaxy facilities.
- USFDA import ban on Ranbaxy's Mohali plant to hit future launchesWith the problems with the USFDA showing no signs of abating, investors are unlikely to repose confidence in the stock any time soon.
- Ranbaxy dives over 30%; m-cap down by Rs 5,855 crore on USFDA import alertA massive sell-off in the stock sent the company's market value down by Rs 5,855 crore to Rs 13,491 crore.
- Ranbaxy Laboratories ends 30% lower on USFDA import alert for Mohali plantRanbaxy Laboratories plunged 35% on Monday on reports that USFDA has issued an import alert for drugs manufactured at its plant in Mohali.
- Ranbaxy hits 52-week low on USFDA query on Mohali plantThe stock has plunged over 10 per cent so far in the month of June and has lost more than one-fourth of its value so far in the year 2013.
- Ranbaxy Laboratories shifts production of Lipitor generic to MohaliRanbaxy Laboratories has started shifting production of its generic version of the world's bestselling drug Lipitor from the US to its new ...
- USFDA inspects Ranbaxy's new plant in MohaliThe USFDA did not respond to an e-mail query. The company's share price closed at 515.05, down 2.95% at the Bombay Stock Exchange on Wednes...
- Ranbaxy may wind up Mohali unitThe company sources products from local units now; may outsource manufacturing.
- Ranbaxy seeks to sell drugs from new Mohali plant in USRanbaxy Laboratories has filed for US Food and Drug Administration's (USFDA) approval to sell medicines from its upcoming manufacturing uni...
Load More
